Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at ...

The two lawsuits against Moderna, Pfizer and its partner BioNTech alleges patent infringement related to the mRNA technology ...

Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...

Biotech firm Promosome LLC sued Moderna , Pfizer and BioNTech , in federal court in San Diego, California, on Tuesday, ...

The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...

Promosome, the exclusive licensee of the ’179 patent, disclosed and taught its method of increasing protein expression to Moderna, but Moderna declined to license it. Also Read: US Court Favors ...

Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is ...

Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...

By Campbell Robertson Early in the pandemic, scientists began testing an old TB vaccine against the coronavirus. But the trial enrolled fewer participants than expected as new Covid vaccines were ...

What is the risk of stroke after the COVID-19 vaccine? Researchers have continued to study stroke risk after COVID-19 vaccination. So far, many have found that there’s no increase in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.